516 related articles for article (PubMed ID: 29658372)
1. MiR-340 affects gastric cancer cell proliferation, cycle, and apoptosis through regulating SOCS3/JAK-STAT signaling pathway.
Xiao C; Hong H; Yu H; Yuan J; Guo C; Cao H; Li W
Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):278-283. PubMed ID: 29658372
[TBL] [Abstract][Full Text] [Related]
2. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
Li XD; Li XM; Gu JW; Sun XC
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
Liu H; Chang JK; Hou JQ; Zhao ZH; Zhang LD
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3193-3199. PubMed ID: 28770966
[TBL] [Abstract][Full Text] [Related]
4. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
5. MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3.
Xie J; Wen JT; Xue XJ; Zhang KP; Wang XZ; Cheng HH
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1914-1921. PubMed ID: 29687843
[TBL] [Abstract][Full Text] [Related]
6. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway.
Li M; Zheng R; Yuan FL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5987-5993. PubMed ID: 30280781
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
8. MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.
Zhou QY; Peng PL; Xu YH
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9427-9435. PubMed ID: 31773681
[TBL] [Abstract][Full Text] [Related]
9. SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
Li MZ; Lai DH; Zhao HB; Chen Z; Huang QX; Situ J
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3005-3011. PubMed ID: 28742207
[TBL] [Abstract][Full Text] [Related]
10. MiR-455-5p upregulation in umbilical cord mesenchymal stem cells attenuates endometrial injury and promotes repair of damaged endometrium via Janus kinase/signal transducer and activator of transcription 3 signaling.
Sun D; Jiang Z; Chen Y; Shang D; Miao P; Gao J
Bioengineered; 2021 Dec; 12(2):12891-12904. PubMed ID: 34784837
[TBL] [Abstract][Full Text] [Related]
11. MiR-17 Regulates Prostate Cancer Cell Proliferation and Apoptosis Through Inhibiting JAK-STAT3 Signaling Pathway.
Dai H; Wang C; Yu Z; He D; Yu K; Liu Y; Wang S
Cancer Biother Radiopharm; 2018 Apr; 33(3):103-109. PubMed ID: 29641255
[TBL] [Abstract][Full Text] [Related]
12. Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer.
Xu W; Fu J; Wu H; Sun W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S311-S318. PubMed ID: 29970682
[TBL] [Abstract][Full Text] [Related]
13. 18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3.
Yang Y; Nan Y; Du YH; Huang SC; Lu DD; Zhang JF; Li X; Chen Y; Zhang L; Yuan L
World J Gastroenterol; 2023 Jul; 29(27):4317-4333. PubMed ID: 37545635
[TBL] [Abstract][Full Text] [Related]
14. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9286-9294. PubMed ID: 31773696
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic role of microRNA-19b-3p-mediated SOCS3 in glioma through activation of JAK-STAT pathway.
Li T; Ge H; Yang Q; Wang J; Yin Q; Wang H; Hou G
Metab Brain Dis; 2023 Mar; 38(3):945-960. PubMed ID: 36484970
[TBL] [Abstract][Full Text] [Related]
16. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
[TBL] [Abstract][Full Text] [Related]
17. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.
Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY
Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787
[TBL] [Abstract][Full Text] [Related]
18. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
Li HL; Liang S; Cui JH; Han GY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
[TBL] [Abstract][Full Text] [Related]
19. miR-30 overexpression promotes glioma stem cells by regulating Jak/STAT3 signaling pathway.
Che S; Sun T; Wang J; Jiao Y; Wang C; Meng Q; Qi W; Yan Z
Tumour Biol; 2015 Sep; 36(9):6805-11. PubMed ID: 25840690
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis.
Chu XQ; Wang J; Chen GX; Zhang GQ; Zhang DY; Cai YY
Pathol Res Pract; 2018 Jan; 214(1):151-162. PubMed ID: 29129493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]